EcoDrugPlus

Ensembl ID : ENSNBRG00000004998
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSNBRG00000007635
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSNBRG00000012068
Gene Symbol: -
Cross references: -
10 Possible Orthologues:

Ensembl ID : ENSNBRG00000020705
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSNBRG00000018833
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSNBRG00000011185
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSNBRG00000003385
Gene Symbol: S1PR1
1 Cross references
200 Possible Orthologues:

Ensembl ID : ENSNBRG00000021933
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSNBRG00000014464
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSNBRG00000001948
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSNBRG00000013074
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSNBRG00000010894
Gene Symbol: -
Cross references: -
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).